查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1579662

全球獸醫分子診斷市場

Veterinary Molecular Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球獸醫分子診斷市場將達到9.842億美元

2023年全球獸醫分子診斷市場估計為5.965億美元，預計到2030年將達到9.842億美元，2023年至2030年複合年成長率為7.4%。設備和軟體是本報告分析的細分市場之一，預計複合年成長率為 7.2%，到分析期結束時將達到 3.428 億美元。分析期內，套件和試劑細分市場的複合年成長率預計為 8.3%。

美國市場預計為1.567億美元，中國預計複合年成長率為11.0%。

預計 2023 年美國獸醫分子診斷市場規模將達 1.567 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達2.389億美元，2023-2030年分析期間複合年成長率為11.0%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.9% 和 6.6%。在歐洲，德國的複合年成長率預計為 4.6%。

全球獸醫分子診斷市場—探索主要趨勢和市場促進因素

為什麼獸醫分子診斷會徹底改變動物健康管理？

獸醫分子診斷已成為動物保健領域的創新工具，可以在分子層面上準確、快速地檢測疾病。但為什麼這種診斷方法對現代獸醫學至關重要？獸醫分子診斷是一種先進的檢測技術，可識別動物病原體、腫瘤和遺傳疾病中的遺傳物質，例如 DNA 和 RNA。這些測試包括聚合酵素鏈鎖反應（PCR）、即時PCR、次世代定序（NGS）和微陣列，可以高靈敏度和特異性地檢測和量化病原體、基因突變和生物標記。透過針對疾病的遺傳基礎，這些診斷使獸醫能夠及早診斷病情，通常是在臨床症狀出現之前，為及時干預和治療提供關鍵資訊。

通用感染疾病的流行、動物慢性和傳染病發病率的上升以及人們對預防性保健的興趣日益濃厚，推動了對獸醫分子診斷的需求。這些診斷廣泛用於檢測細小病毒、貓白血病和牛呼吸道疾病等感染疾病，以及育種計畫中的基因篩檢以防止遺傳性疾病的傳播。分子診斷用於識別可以指南癌症治療標靶治療的特定突變和生物標記。此外，區分密切相關的病原體並在一次測試中檢測多種病原體的能力使得分子診斷成為傳統測試方法不足的複雜病例的首選。隨著寵物飼主、牲畜管理者和獸醫尋求更準確、更可靠的診斷解決方案，獸醫分子診斷在動物健康管理中發揮越來越重要的作用。

技術進步如何提高獸醫分子診斷的性能？

獸醫分子診斷市場經歷了重大的技術進步，提高了這些診斷工具的準確性、速度和可近性。但推動這些發展的關鍵技術創新是什麼？最有影響力的進步之一是即時PCR(qPCR) 技術的發展。 qPCR 已成為獸醫診斷的黃金標準，因為它能夠即時擴增和定量 DNA 或 RNA 序列，從而提供快速、靈敏的結果。現代 qPCR 系統具有多重功能，可以同時檢測一份樣本中的多種病原體和遺傳標記。這項創新顯著縮短了周轉時間，並消除了多次測試的需要，使獸醫能夠做出更快、更明智的決定。此外，自動化樣品製備系統的整合簡化了工作流程，減少了人為錯誤的可能性，並提高了測試結果的一致性和可靠性。

另一項重要的創新是次世代定序儀（NGS）技術的出現，它徹底改變了獸醫基因體學領域。 NGS 透過對整個基因組或感興趣區域進行定序來實現全面的遺傳分析，從而深入了解複雜的遺傳特徵、疾病機制和微生物群落。該技術擴大應用於研究和臨床環境中，例如病原體發現、抗菌藥物抗藥性監測和癌症基因分型等。攜帶式照護現場分子診斷設備的發展進一步擴大了這些技術的範圍，使獸醫能夠在現場進行測試，例如在診所、農場和野外。這些儀器設計為使用者友善型，需要最少的培訓和基礎設施，即使在偏遠和資源有限的環境中也可以進行先進的分子診斷。此外，生物資訊學和資料分析的進步正在增強對分子診斷結果的解釋，並實現更準確和可操作的見解。這些創新提高了獸醫分子診斷的性能和實用性，使其成為現代獸醫學的重要工具。

哪些市場趨勢正在推動獸醫分子診斷在動物保健領域的傳播？

一些新興市場趨勢正在影響獸醫分子診斷在動物保健領域的應用，反映了獸醫、研究人員和飼主不斷變化的需求和期望。最顯著的趨勢之一是越來越關注預防醫學和疾病的早期發現。隨著寵物飼主和牲畜管理者越來越意識到早期診斷的好處，對能夠在症狀出現或傳播到其他動物之前在亞臨床階段檢測疾病的診斷工具的需求正在增加。獸醫分子診斷具有高靈敏度和特異性，非常適合此目的，可以及早識別感染疾病病原體、遺傳性疾病和癌細胞。這種趨勢在伴同性動物領域尤其明顯，定期健康檢查和健康計畫變得越來越普遍。儘早發現遺傳傾向和感染疾病的能力使獸醫能夠實施有針對性的預防措施並制定個性化的治療計劃，從而改善健康結果並降低長期治療成本。

推動獸醫分子診斷採用的另一個重要趨勢是通用感染疾病的日益普及以及有效疾病監測的需要。動物和人類之間傳播的通用感染疾病是重大的公共衛生風險，早期準確的診斷對於遏制疾病爆發和防止跨物種傳播至關重要。 COVID-19 大流行凸顯了強大的疾病監測系統的重要性，並導致對伴同性動物和牲畜診斷基礎設施的投資增加。獸醫分子診斷在這項工作中發揮關鍵作用，它提供了快速、準確地檢測通用感染疾病的工具，支持追蹤和控制疾病傳播的努力。這種趨勢在北美和歐洲等牲畜數量較多的地區尤其明顯，這些地區利用分子診斷技術來監測禽流感、牛結核病和非洲豬瘟等疾病。對全面疾病監測和生物安全措施不斷成長的需求預計將繼續推動公共和私營部門採用分子診斷，加強其作為動物健康管理重要工具的角色。

推動全球獸醫分子診斷市場成長的因素有哪些？

全球獸醫分子診斷市場的成長受到多種因素的推動，例如診斷技術的進步、動物保健投資的增加以及對通用感染疾病的認知不斷提高。主要成長要素之一是寵物數量的擴大和寵物的人性化，飼主將他們的動物視為家庭的一部分，並願意投資先進的醫療保健服務。這導致對能夠提供快速、準確結果、從而實現早期診斷和有效治療的診斷測試的需求激增。使用者友好的自動化分子診斷平台的開拓使獸醫醫院和診所更容易將這些測試納入其常規診斷業務，進一步促進市場成長。隨著農民和生產者尋求改善牛健康、生產力和疾病管理，分子診斷在牲畜管理中的日益使用也是一個主要驅動力。

感染疾病發生率上升以及有效疾病管理和控制的需求也是重要的促進因素。禽流感、非洲豬瘟、犬細小病毒等疾病的爆發凸顯了快速、準確診斷對於防止疾病傳播和最大程度減少經濟損失的重要性。獸醫分子診斷為病原體檢測和區分提供了可靠的解決方案，使獸醫能夠及時實施有針對性的干涉措施。對抗菌素抗藥性（AMR）的興趣日益濃厚也促進了市場的成長。這是因為分子診斷可以透過識別抗藥性基因並指導適當使用抗生素來降低抗藥性發展的風險。此外，獸醫診斷實驗室和研究機構的擴張，特別是在亞太和拉丁美洲等新興市場，正在為市場成長創造新的機會。全球獸醫分子診斷市場受到技術創新、不斷發展的醫療保健實踐、動物和公共衛生的推動，因為這些地區投資於獸醫基礎設施現代化和改善先進診斷技術的獲取，預計不斷成長的意識的動態相互作用將帶來持續的發展。

調查企業範例（共42例）

  • BIOMEDICA Medizinprodukte GmbH & Co., KG
  • Bioneer Corporation
  • HealthGene Corporation
  • Idexx Laboratories, Inc.
  • Novacyt Group
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
  • Vca, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP16891

Global Veterinary Molecular Diagnostics Market to Reach US$984.2 Million by 2030

The global market for Veterinary Molecular Diagnostics estimated at US$596.5 Million in the year 2023, is expected to reach US$984.2 Million by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$342.8 Million by the end of the analysis period. Growth in the Kits & Reagents segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$156.7 Million While China is Forecast to Grow at 11.0% CAGR

The Veterinary Molecular Diagnostics market in the U.S. is estimated at US$156.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$238.9 Million by the year 2030 trailing a CAGR of 11.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Veterinary Molecular Diagnostics Market - Key Trends & Growth Drivers Explored

Why Are Veterinary Molecular Diagnostics Revolutionizing Animal Health Management?

Veterinary molecular diagnostics have emerged as a transformative tool in animal healthcare, enabling precise and rapid detection of diseases at the molecular level. But what makes these diagnostic methods so essential in modern veterinary practices? Veterinary molecular diagnostics are advanced testing techniques that identify genetic material, such as DNA and RNA, from pathogens, tumors, or genetic disorders in animals. These tests include polymerase chain reaction (PCR), real-time PCR, next-generation sequencing (NGS), and microarrays, among others, which can detect and quantify pathogens, genetic mutations, or biomarkers with high sensitivity and specificity. By targeting the genetic basis of diseases, these diagnostics allow veterinarians to diagnose conditions early, often before clinical symptoms appear, providing a crucial window for timely intervention and treatment.

The demand for veterinary molecular diagnostics is driven by the growing prevalence of zoonotic diseases, the rising incidence of chronic and infectious conditions in animals, and the increasing focus on preventive healthcare. These diagnostics are widely used in the detection of infectious diseases such as parvovirus, feline leukemia, and bovine respiratory disease, as well as for genetic screening in breeding programs to prevent the transmission of hereditary disorders. Molecular diagnostics have also become indispensable in the field of oncology, where they are used to identify specific mutations and biomarkers that can guide targeted therapies for cancer treatment. Furthermore, the ability to differentiate between closely related pathogens and detect multiple pathogens in a single test has made molecular diagnostics a preferred choice in complex cases where traditional testing methods may fall short. As pet owners, livestock managers, and veterinarians seek more accurate and reliable diagnostic solutions, veterinary molecular diagnostics are poised to play an increasingly central role in animal health management.

How Are Technological Advancements Elevating the Performance of Veterinary Molecular Diagnostics?

The veterinary molecular diagnostics market has experienced significant technological advancements that have enhanced the precision, speed, and accessibility of these diagnostic tools. But what are the key innovations driving these developments? One of the most impactful advancements is the evolution of real-time PCR (qPCR) technology. qPCR has become a gold standard in veterinary diagnostics due to its ability to amplify and quantify DNA or RNA sequences in real-time, providing rapid and highly sensitive results. Modern qPCR systems are equipped with multiplexing capabilities, allowing the simultaneous detection of multiple pathogens or genetic markers in a single sample. This innovation has significantly reduced turnaround times and the need for multiple tests, enabling veterinarians to make quicker and more informed decisions. Additionally, the integration of automated sample preparation systems has streamlined the workflow, reducing the potential for human error and increasing the consistency and reliability of test results.

Another critical innovation is the advent of next-generation sequencing (NGS) technology, which has revolutionized the field of veterinary genomics. NGS allows for comprehensive genetic analysis by sequencing entire genomes or targeted regions of interest, providing insights into complex genetic traits, disease mechanisms, and microbial communities. This technology is being increasingly used in research and clinical settings for applications such as pathogen discovery, antimicrobial resistance monitoring, and cancer genotyping. The development of portable and point-of-care molecular diagnostic devices has further expanded the reach of these technologies, enabling veterinarians to conduct testing on-site, whether in clinics, farms, or field settings. These devices are designed to be user-friendly, requiring minimal training and infrastructure, making advanced molecular diagnostics accessible even in remote or resource-limited environments. Furthermore, advancements in bioinformatics and data analytics have enhanced the interpretation of molecular diagnostic results, allowing for more accurate and actionable insights. These technological innovations have collectively elevated the performance and utility of veterinary molecular diagnostics, making them indispensable tools for modern veterinary medicine.

What Market Trends Are Driving the Adoption of Veterinary Molecular Diagnostics Across Animal Healthcare?

Several emerging market trends are shaping the adoption of veterinary molecular diagnostics across the animal healthcare sector, reflecting the evolving needs and expectations of veterinarians, researchers, and pet owners. One of the most prominent trends is the increasing focus on preventive care and early disease detection. As pet owners and livestock managers become more aware of the benefits of early diagnosis, there is a growing demand for diagnostic tools that can detect diseases at the subclinical stage, before they become symptomatic or spread to other animals. Veterinary molecular diagnostics, with their high sensitivity and specificity, are well-suited for this purpose, allowing for the early identification of infectious agents, genetic disorders, and cancerous cells. This trend is particularly strong in the companion animal sector, where regular health screenings and wellness programs are becoming more common. The ability to detect genetic predispositions and infectious diseases early enables veterinarians to implement targeted preventive measures and develop personalized treatment plans, improving health outcomes and reducing the long-term costs of care.

Another key trend driving the adoption of veterinary molecular diagnostics is the rising prevalence of zoonotic diseases and the need for effective disease surveillance. Zoonotic diseases, which are transmitted between animals and humans, pose a significant public health risk, making early and accurate diagnosis essential for controlling outbreaks and preventing cross-species transmission. The COVID-19 pandemic has underscored the importance of robust disease surveillance systems, leading to increased investment in diagnostic infrastructure for both companion animals and livestock. Veterinary molecular diagnostics are playing a critical role in this effort by providing tools that can detect zoonotic pathogens rapidly and accurately, supporting efforts to track and control disease spread. This trend is particularly evident in regions with large livestock populations, such as North America and Europe, where molecular diagnostics are used to monitor diseases like avian influenza, bovine tuberculosis, and African swine fever. The growing demand for comprehensive disease surveillance and biosecurity measures is expected to continue driving the adoption of molecular diagnostics in both the public and private sectors, reinforcing their role as key instruments in animal health management.

What Factors Are Driving the Growth of the Global Veterinary Molecular Diagnostics Market?

The growth in the global veterinary molecular diagnostics market is driven by several factors, including advancements in diagnostic technology, increasing investment in animal healthcare, and rising awareness of zoonotic diseases. One of the primary growth drivers is the expanding pet population and the humanization of pets, where owners treat their animals as family members and are willing to invest in advanced healthcare services. This has led to a surge in demand for diagnostic tests that provide quick and accurate results, enabling early diagnosis and effective treatment. The development of user-friendly and automated molecular diagnostic platforms has made it easier for veterinary clinics and hospitals to incorporate these tests into their routine diagnostic offerings, further boosting market growth. The increasing use of molecular diagnostics in livestock management is another key growth driver, as farmers and producers seek to improve herd health, productivity, and disease control.

Another significant growth driver is the rising incidence of infectious diseases and the growing need for effective disease management and control. Outbreaks of diseases like avian influenza, African swine fever, and canine parvovirus have highlighted the importance of rapid and accurate diagnostics for preventing disease spread and minimizing economic losses. Veterinary molecular diagnostics provide a reliable solution for detecting and differentiating pathogens, enabling veterinarians to implement timely and targeted interventions. The growing focus on antimicrobial resistance (AMR) is also contributing to market growth, as molecular diagnostics can identify resistance genes and guide the appropriate use of antibiotics, reducing the risk of resistance development. Furthermore, the expansion of veterinary diagnostic laboratories and research institutions, particularly in emerging markets such as Asia-Pacific and Latin America, is creating new opportunities for market growth. As these regions invest in modernizing their veterinary infrastructure and improving access to advanced diagnostic technologies, the global veterinary molecular diagnostics market is poised for sustained expansion, driven by a dynamic interplay of technological innovation, evolving healthcare practices, and increasing awareness of animal and public health.

Select Competitors (Total 42 Featured) -

  • BIOMEDICA Medizinprodukte GmbH & Co., KG
  • Bioneer Corporation
  • HealthGene Corporation
  • Idexx Laboratories, Inc.
  • Novacyt Group
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
  • Vca, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Veterinary Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Infectious Diseases in Companion and Livestock Animals Drives Demand for Veterinary Molecular Diagnostics
    • Increased Adoption of Molecular Diagnostic Techniques in Veterinary Clinics and Laboratories Expands Addressable Market
    • Rising Use of Molecular Diagnostics in Zoonotic Disease Surveillance Sets the Stage for Market Growth
    • Surge in Demand for Molecular Diagnostic Tests in Food Safety and Animal Health Monitoring Expands Market Opportunities
    • Growing Adoption of Molecular Diagnostics in Veterinary Oncology and Genetic Disease Testing Strengthens Business Case
    • Technological Advancements in Multiplex and High-Throughput Molecular Diagnostic Platforms Propel Market Expansion
    • Growing Use of Molecular Diagnostics in Animal Reproductive Health and Fertility Management Strengthens Market Growth
    • Surge in Use of Molecular Diagnostic Techniques in Wildlife and Conservation Medicine Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Veterinary Molecular Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Instruments & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals/Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals/Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals/Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • JAPAN
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • CHINA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • EUROPE
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • FRANCE
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • GERMANY
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • INDIA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030
  • AFRICA
    • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Veterinary Molecular Diagnostics by Product Segment - Instruments & Software, Kits & Reagents and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by Product Segment - Percentage Breakdown of Value Sales for Instruments & Software, Kits & Reagents and Services for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Veterinary Molecular Diagnostics by Technology Type - Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by Technology Type - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA Sequencing for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Veterinary Molecular Diagnostics by End-Use - Hospitals/Clinics and Reference Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals/Clinics and Reference Laboratories for the Years 2014, 2024 & 2030

IV. COMPETITION